# Novo explores macrocycles’ potential in $1.4B cardiometabolic pact with Danish biotech

> **Newsylist Open Intelligence Dossier** · First detected: 2026-09-17 20:29 UTC · Category: Business · Sources: 6 · Current Velocity: 3.67

## Key People, Organizations & Locations
Danish, Novo

## Multi-Source Evidence Table
| Source Outlet | Headline | Published (UTC) | Verification URL |
|---|---|---|---|
| biopharmadive.com | Novo partners with Orbis, deepening investment in oral peptide drugs | 2026-09-17 10:56 | [Source Link](https://news.google.com/rss/articles/CBMimAFBVV95cUxOWEw3NktMQjVFLXZWcWVHZE1kamRLXzdITWlFUnV1M2pVTndmWnFodFM5UVhEM1JSQWFsRnZiZ0xxUElxV1VjenhacUdhOF9raEJsV1d3TUJvLUEtX1F0MThNeFhteTR4VWtRc3RkMHlSOVJHVXhUdHdlTjlWV1diUVMyX2RlVjJQUnFIekNxZEdQOGlwbG9fdw?oc=5) |
| marketscreener.com | Novo Nordisk Signs Agreement With Orbis Medicines to Develop Therapeutics for Cardiometabolic Diseases | 2026-09-17 10:56 | [Source Link](https://news.google.com/rss/articles/CBMi6AFBVV95cUxQRWZhN0QtNXJteEVTWW1EazJVOU1sTHZyZ3JrRzFhdTFNR2xZZmcxWk1NRTNsNUp0T09UME4xY3RXQnB4WUtkMUdJU3p0RTcwamFoMTlWRW8xYldaNlFzQVhtc2J0bjU3c3ZqV0RNVkpjVjZaVVA4OFhkY1g0bmNGMVZCTzM2alJCQ3RBM29pdnJwaWVyRUVQN3hIdDdaeEJ6YkNjTlUtTmQtUldlNHRsZ3pkUHh3elU3WDBPeklqWkJybHVCQ044M2J5NUZaMlJ0TlRPT0ZQZXBTTC1XQWJtcVdRUXdSQTBm?oc=5) |
| endpoints.news | Lilly-backed Orbis does up to $1.4B macrocycle deal with Novo | 2026-09-17 10:56 | [Source Link](https://news.google.com/rss/articles/CBMijAFBVV95cUxNaU93SHdhQVMzVlMzbEMtVmdWbkp5cjhfb1NLU3dnRXNBZ0ZXb2g5WGRVWHpSZnVlX0NVRFVlMmVHTUZ0TWhOZkwyc1U2MnVNNU1yci1TT2Y1ZTh3LV9MWmNkUkF3RHNIWTZudkpaUWVJc3NRRFAybEVNbmJhUW5Vcmp6TkxlekcwNWt1eA?oc=5) |
| Yahoo Finance | Novo Nordisk Signs Up To $1.4 Billion Licensing Deal With Orbis Medicines | 2026-09-17 10:56 | [Source Link](https://news.google.com/rss/articles/CBMiiwFBVV95cUxOWlZvSzhoNjE2VDBrR2tQRXI0VTZMc3V4RzJqcGlzUEpsY0Jfb2V2UGQtQXVLdHhSU2FCeTV1anZFQ0ZQaXBqclRIbGxuSEJXTU5nSDdaaWd2T2xUT1hUTXdFOERlWHBOcWUyNmMzX05RTnFXVl9tVExsQVhuNXdJMEhvY0gwbURkT2Vr?oc=5) |
| Reuters | Novo, Orbis sign up to $1.4 billion deal to develop oral drugs | 2026-09-17 10:56 | [Source Link](https://news.google.com/rss/articles/CBMiqgFBVV95cUxNZEpTSXdZaXJKZU1mRkFwczRkakJpbXNpdWhTVWMwbGpzZ0hxaVJzcXE2QlZwOTEyOWVhZFQxVml4RjZFRVNYYS1OdG1IQk8yeFh4TXVGeHBDY3IydFRhUnRMMUtRX1ZJanJ0c21Nanp1VHltRWpmTHlXMUlJaTktVzRzSzFYaFdmWHlDRDhyZG1kSjc4NFRNb1VuUGltTENTSmlnNHJnU2M0Zw?oc=5) |
| Fierce Biotech | Novo explores macrocycles’ potential in $1.4B cardiometabolic pact with Danish biotech | 2026-09-17 10:56 | [Source Link](https://news.google.com/rss/articles/CBMiswFBVV95cUxNa2c5OVVReW1FMUlQa2h2YlRPS3ZMc3JVa2NPQ1RNS2thRU5sS3VnZWVJalFGMXJaM0hiQmhkLXRvT01WYXgtc3ZCU3REaVpYSG1YRHlMUkN5NmZWRi1RM0RzTXIxUDc0bzVnd3h2dkoyNWZ1UFVyTVNQVXZMOUJkQy1wSEZQMF9PQ2dGTFJBRFpYc0N3OHdtRVE3cE9yaGRQa0R6VHoxTzM2Nm80bEdWeExEcw?oc=5) |

---
*Canonical Source: https://www.newsylist.com/trend/2026-09-17/novo-explores-macrocycles-potential-in-1-4b-cardiometabolic-pact-with-danish*
*Synthesized by Newsylist Open Intelligence Engine under E-E-A-T journalistic standards.*